Peptides
Subcategories of "Peptides"
Found 29890 products of "Peptides"
TTC5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TTC5 antibody, catalog no. 70R-2121
Purity:Min. 95%CLDN2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CLDN2 antibody, catalog no. 20R-1258
Purity:Min. 95%ZCCHC13 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZCCHC13 antibody, catalog no. 70R-4279
Purity:Min. 95%COPA Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of COPA antibody, catalog no. 70R-6205
Purity:Min. 95%MAN1A2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MAN1A2 antibody, catalog no. 70R-6984
Purity:Min. 95%VDR Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of VDR antibody, catalog no. 70R-1930Purity:Min. 95%AGXT2L1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of AGXT2L1 antibody, catalog no. 70R-2601
Purity:Min. 95%ABCD4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ABCD4 antibody, catalog no. 70R-1784
Purity:Min. 95%SLCO1C1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLCO1C1 antibody, catalog no. 70R-6553
Purity:Min. 95%HECTD2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PAPPA2 antibody, catalog no. 70R-5402
Purity:Min. 95%MTHFS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of MTHFS antibody, catalog no. 70R-3776
Purity:Min. 95%CDCA5 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CDCA5 antibody, catalog no. 70R-2883
Purity:Min. 95%CCBP2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CCBP2 antibody, catalog no. 70R-7846
Purity:Min. 95%ACADS Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACADS antibody, catalog no. 70R-2485
Purity:Min. 95%CPSF1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CPSF1 antibody, catalog no. 70R-4864
Purity:Min. 95%C9ORF68 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of C9orf68 antibody, catalog no. 70R-4309
Purity:Min. 95%PYHIN1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PYHIN1 antibody, catalog no. 70R-9020
Purity:Min. 95%WDFY3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of WDFY3 antibody, catalog no. 70R-9011
Purity:Min. 95%Zfp275 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Zfp275 antibody, catalog no. 70R-8773
Purity:Min. 95%COL1A1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of COL1A1 antibody, catalog no. 70R-9963Purity:Min. 95%EIF2C4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of EIF2C4 antibody, catalog no. 70R-3041
Purity:Min. 95%KHDRBS1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of KHDRBS1 antibody, catalog no. 70R-5674
Purity:Min. 95%TXNDC13 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TXNDC13 antibody, catalog no. 70R-7432
Purity:Min. 95%Adropin (Human, 34-76)
CAS:Adropin is a peptide that binds to the activator domain of phospholipase A2 (PLA2) and inhibits the enzyme. It has been shown to be an inhibitor of PLA2 in human, mouse, and rat cells. Adropin can also inhibit ion channels and cell signaling pathways by binding to cell surface receptors. This research tool may be used for studying protein interactions and pharmacology.
Formula:C190H293N55O68S2Purity:Min. 95%Molecular weight:4,499.8 g/molScara3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Scara3 antibody, catalog no. 70R-8675
Purity:Min. 95%GJA8 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of GJA8 antibody, catalog no. 70R-6106
Purity:Min. 95%SPACA1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SPACA1 antibody, catalog no. 70R-8848
Purity:Min. 95%CGB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CGB antibody, catalog no. 70R-9986
Purity:Min. 95%CPEB2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CPEB2 antibody, catalog no. 70R-4851
Purity:Min. 95%Leu-Gly-Gly
CAS:Leu-Gly-Gly is a cyclic peptide that binds to fibrinogen and forms stable complexes with the enzyme form of human serum albumin. It is used as a model system for studying the structure of proteins, and has been shown to bind calcium ions. Leu-Gly-Gly is also an amide and can form stable complexes with basic proteins such as fibrinogen. This peptide also has significant cytotoxicity against polymorphonuclear leucocytes, which may be due to its ability to inhibit polymerase chain activity.
Formula:C10H19N3O4Purity:Min. 95%Molecular weight:245.28 g/molDPH2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DPH2 antibody, catalog no. 70R-3392
Purity:Min. 95%DYDC1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of DYDC1 antibody, catalog no. 70R-4150
Purity:Min. 95%PLCD1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PLCD1 antibody, catalog no. 70R-5826
Purity:Min. 95%FCRL1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FCRL1 antibody, catalog no. 70R-1853
Purity:Min. 95%CANT1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CANT1 antibody, catalog no. 70R-5814
Purity:Min. 95%Beta-Sheet Breaker Peptide iAß5
CAS:Beta-Sheet Breaker Peptide iAß5 is a peptide that interacts with amyloid beta proteins to disrupt the formation of beta sheets. It has been shown to inhibit the aggregation of amyloid beta proteins into oligomers and fibrils, and disrupts the self-assembly of amyloid beta protein into various conformations. Beta-Sheet Breaker Peptide iAß5 is a ligand for both receptor and activator binding sites on amyloid beta proteins, inhibiting the interaction of these sites. This inhibits the activation of downstream signalling pathways associated with Alzheimer's disease.
Formula:C33H43N5O8Purity:Min. 95%Molecular weight:637.72 g/molSTAT5B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of STAT5B antibody, catalog no. 20R-1134
ASL Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ASL antibody, catalog no. 70R-1176
Purity:Min. 95%Cyb5r1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Cyb5r1 antibody, catalog no. 70R-8676
Purity:Min. 95%SLC1A4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC1A4 antibody, catalog no. 70R-6961
Purity:Min. 95%FBLN1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FBLN1 antibody, catalog no. 70R-5356
Purity:Min. 95%Hps3 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of Hps3 antibody, catalog no. 70R-7822
Purity:Min. 95%PALM Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of PALM antibody, catalog no. 70R-9381
Purity:Min. 95%ZDHHC14 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ZDHHC14 antibody, catalog no. 70R-7047
Purity:Min. 95%TAPBP Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of TAPBP antibody, catalog no. 70R-6000
Purity:Min. 95%Crustacean Erythrophore Concentrating Hormone
Catalogue peptide; min. 95% purity
Formula:C45H59N11O11Molecular weight:930.04 g/molBig Gastrin-1, human
Catalogue peptide; min. 95% purity
Formula:C176H251N43O53SMolecular weight:3,849.30 g/molP69 (522-534), M. leprae
Catalogue peptide; min. 95% purity
Formula:C52H84N14O21Molecular weight:1,241.33 g/molAc-Adhesin (1025-1044) amide
Catalogue peptide; min. 95% purity
Formula:C97H160N26O32Molecular weight:2,202.51 g/molAc-Choline Receptor α1(129-145)
Catalogue peptide; min. 95% purity
Formula:C90H136N22O28S2Molecular weight:2,038.34 g/molDisulfide biotin azide
CAS:Extraordinary strength of the streptavidin-biotin interaction allows for efficient capturing of even highly dilute targets; however, it makes recovery of proteins from affinity resins challenging. Conventional methods to elute biotinylated proteins from immobilized avidin include the following: (i) denaturation of streptavidin by boiling the resin in a denaturing buffer that may include high concentrations of chaotropic salts, (ii) trypsin digestion of proteins while they are bound to the resin, or (iii) elution of proteins with excess free biotin. These protocols can co-elute contaminant proteins by releasing nonspecifically bound proteins and/or naturally biotinylated proteins concurrently with labeled proteins. In addition, some of these methods can cause elution of high levels of resin-based peptides along with the proteins of interest, resulting in further sample contamination.
Disulfide Biotin Azide probe eliminates a major limitation of the streptavidin-biotin affinity purification. This reagent contains a biotin moiety linked to an azide moiety through a spacer arm containing a cleavable disulfide linker. Captured biomolecules can be efficiently released under mild conditions (50 mM dithiothreitol, 10 mM 2-mercaptoethanol or 1% sodium borohydride) and the small molecular fragment (188.25 Da) left on the labeled protein following cleavage. These features make the cleavable probe especially attractive for use in biomolecular labeling and proteomic studies.Formula:C27H48N8O7S3Purity:Min 95%Molecular weight:692.92 g/molBTK derived peptide
Catalogue peptide; min. 95% purity
Formula:C72H115N17O18S2Molecular weight:1,570.95 g/molPrepro TRH (53-74)
Catalogue peptide; min. 95% purity
Formula:C118H182N32O32Molecular weight:2,560.96 g/molInsulin Receptor (1142-1153)
Catalogue peptide; min. 95% purity
Formula:C72H107N19O24Molecular weight:1,622.77 g/mol[Ile12, Val15] MUC5AC Analog 3
Catalogue peptide; min. 95% purity
Formula:C67H112N16O25Molecular weight:1,541.73 g/molAc-a-CGRP (19-37) (human)
Catalogue peptide; min. 95% purity
Formula:C88H139N25O26Molecular weight:1,963.24 g/mol[D-Arg25]-Neuropeptide Y, human, rat
Catalogue peptide; min. 95% purity
Formula:C189H285N55O57SMolecular weight:4,271.67 g/molAngiotensin II type 1 receptor (181-187), AT1, ATE.
Catalogue peptide; min. 95% purity
Formula:C40H52N10O13Molecular weight:880.92 g/molIntermedin (rat)
Catalogue peptide; min. 95% purity
Formula:C226H361N75O64S2Molecular weight:5,216.99 g/mol2A/2B Dengue Protease Substrate
Catalogue peptide; min. 95% purity
Formula:C39H68N16O11Molecular weight:937.08 g/molCorticostatin, human
Catalogue peptide; min. 95% purity
Formula:C157H261N49O43S6Molecular weight:3,715.47 g/molFluorescein-6-carbonyl-Leu-Glu(OMe)-His-DL-Asp(OMe)-fluoromethylketone
CAS:Please enquire for more information about Fluorescein-6-carbonyl-Leu-Glu(OMe)-His-DL-Asp(OMe)-fluoromethylketone including the price, delivery time and more detailed product information at the technical inquiry form on this page
Formula:C45H47FN6O14Purity:Min. 95%Molecular weight:914.89 g/mol[Trp11] Neurotensin (8-13)
Catalogue peptide; min. 95% purity
Formula:C40H65N13O7Molecular weight:840.05 g/molFMRF-related peptide, SDPFLRF-NH2
Catalogue peptide; min. 95% purity
Formula:C42H61N11O10Molecular weight:880.02 g/molGrowth Hormone Releasing Factor, GRF (1-40), amide, human
Catalogue peptide; min. 95% purity
Formula:C194H318N62O62SMolecular weight:4,543.14 g/mol[Arg0] Met-Enkephalin
Catalogue peptide; min. 95% purity
Formula:C33H47N9O8SMolecular weight:729.86 g/molγ-TAC4 (32-50)
Catalogue peptide; min. 95% purity
Formula:C92H146N24O31Molecular weight:2,084.33 g/molBrain injury Derived Neurotrophic Peptide(3) BINP
Catalogue peptide; min. 95% purity
Formula:C62H101N17O19Molecular weight:1,388.58 g/molADP-Ribosylation Factor 6, ARF6 (2-13)
Catalogue peptide; min. 95% purity
Formula:C60H102N16O17Molecular weight:1,319.58 g/mol[Ala8]-Humanin, [Ala8]-HN, Shna
Catalogue peptide; min. 95% purity
Formula:C119H204N34O32SMolecular weight:2,655.23 g/molSomatostatin-28 (1-14)
Catalogue peptide; min. 95% purity
Formula:C61H105N23O21SMolecular weight:1,528.72 g/mol[Phe22] Big Endothelin-1 (19-37), human
Catalogue peptide; min. 95% purity
Formula:C104H152N26O26Molecular weight:2,182.53 g/molBiotin-Galanin, human
Catalogue peptide; min. 95% purity
Formula:C149H224N44O45SMolecular weight:3,383.78 g/molbeta-Lipotropin (1-10), porcine
Catalogue peptide; min. 95% purity
Formula:C42H66N10O15Molecular weight:951.05 g/mol[Tyr0]-α-CGRP, [Tyr0]-α-CGRP, rat
Catalogue peptide; min. 95% purity
Formula:C171H271N51O54S2Molecular weight:3,969.50 g/molBiotin-[Tyr0]-Orexin B, mouse, rat
Catalogue peptide; min. 95% purity
Formula:C145H238N48O38S2Molecular weight:3,325.86 g/molMyelin Oligodendrocyte Glycoprotein (35-55) (mouse, rat) trifluoroacetate
CAS:Myelin oligodendrocyte glycoprotein (MOG) is a myelin protein found in the central nervous system. MOG is a ligand for CD200, which is an inhibitory receptor expressed by astrocytes. It has been shown that MOG can induce the proliferation and differentiation of primary cultures of rat astrocytes in vitro. MOG induces the production of reactive oxygen species in mitochondria and increases the expression of acid-binding protein, which are both important factors in the demyelination process. MOG has also been implicated as a potential factor in the development of multiple sclerosis. Further research into this protein may lead to new treatments or cures for disorders such as encephalomyelitis, nervous system diseases, or even cancer.
Formula:C118H177N35O29S•C2HO2F3Purity:Min. 95%Color and Shape:PowderMolecular weight:2,695.98 g/molCJC-1295
CAS:CJC-1295 is a synthetic peptide, which is an analogue of growth hormone-releasing hormone (GHRH). It is synthesized through recombinant DNA technology, which allows for precise control over its sequence and length. This particular peptide is designed to bind to GHRH receptors in the pituitary gland. By activating these receptors, CJC-1295 stimulates the release of growth hormone (GH) into the bloodstream.The primary function of CJC-1295 is to influence the endocrine system, particularly enhancing the release of endogenous growth hormone. It achieves this by increasing the amplitude and frequency of GH pulses without affecting the natural negative feedback mechanisms that regulate GH production. This mode of action distinguishes CJC-1295 from other growth hormone therapies, as it promotes a more physiological pattern of hormone secretion.CJC-1295 is used in various scientific contexts, primarily in research focusing on growth hormone deficiencies, muscle wasting conditions, and certain metabolic disorders. Its ability to increase GH release also makes it a subject of interest in studies related to aging, tissue repair, and regeneration. The longer half-life of CJC-1295 compared to natural GHRH peptides further enhances its applications in research, allowing for more sustained and controlled experimentation.
Purity:Min. 95%Ref: 3D-FC138107
Discontinued productp3K truncated, (Lys 58 Lys 60 Lys 63) Ea(54-68)
Catalogue peptide; min. 95% purity
Formula:C59H97N17O19Molecular weight:1,348.53 g/molH-His-Arg-OH
CAS:H-His-Arg-OH is a synthetic peptide that has been shown to have cytotoxic effects on mammalian cells. The H-His-Arg-OH peptide can be used for the treatment of heart disease and autoimmune diseases, such as rheumatoid arthritis. This peptide has been found to be resistant to congestive heart failure, which is caused by a number of factors, including hypertension and valvular stenosis. It has also been shown to have an immunoglobulin G1 (IgG1) genotype.
Formula:C12H21N7O3Purity:Min. 95%Molecular weight:311.34 g/molRef: 3D-FH108062
Discontinued product[D-Tyr27,36, D-Thr32]-Neuropeptide Y, human
Catalogue peptide; min. 95% purity
Formula:C189H285N55O57SMolecular weight:4,271.67 g/molPeptide YY (3-36) (canine, mouse, porcine, rat)
Catalogue peptide; min. 95% purity
Formula:C190H288N54O57Molecular weight:4,240.64 g/mol[Met2]-Deltorphin
Catalogue peptide; min. 95% purity
Formula:C44H62N10O10S2Molecular weight:955.17 g/mol
![[Ile12, Val15] MUC5AC Analog 3](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00456.webp&w=3840&q=75)
![[D-Arg25]-Neuropeptide Y, human, rat](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00909.webp&w=3840&q=75)
![[Trp11] Neurotensin (8-13)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00688.webp&w=3840&q=75)
![[Arg0] Met-Enkephalin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00699.webp&w=3840&q=75)
![[Ala8]-Humanin, [Ala8]-HN, Shna](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00593.webp&w=3840&q=75)
![[Phe22] Big Endothelin-1 (19-37), human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00505.webp&w=3840&q=75)
![[Tyr0]-α-CGRP, [Tyr0]-α-CGRP, rat](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00921.webp&w=3840&q=75)
![Biotin-[Tyr0]-Orexin B, mouse, rat](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00130.webp&w=3840&q=75)
![[D-Tyr27,36, D-Thr32]-Neuropeptide Y, human](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00911.webp&w=3840&q=75)
![[Met2]-Deltorphin](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb-webp%2FVAC-00898.webp&w=3840&q=75)